A Phase 4 interventional study of Ketamine group and Placebo group in Knee Osteoarthritis, sponsored by Ministry of Health, Thailand. Recruiting at 1 site in Thailand. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-12.
Sponsored by Ministry of Health, Thailand · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 44 studies in Osteoarthritis, Knee with a site in Thailand — 7 open to participants now, 9 under way, 2 of them phase 3. Osteoarthritis, Knee · Thailand.
Among the 44 studies in Osteoarthritis, Knee with a site in Thailand, this one is the 17th largest by planned enrollment of the 40 interventional ones that give a count, is one of 5 that started in 2024, is one of 9 in phase 4, and was the 36th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →7 of the 44 studies in Osteoarthritis, Knee with a site in Thailand are open now. Recruiting first, the newest first:
Thammasat University Hospital · Sites in Thailand
Ages 40–80
Phramongkutklao College of Medicine and Hospital · Sites in Thailand
Ages 50+
Thammasat University Hospital · Sites in Thailand
Ages 40–85
Mahidol University · Sites in Thailand
Ages 50–80
Siriraj Hospital · Sites in Thailand
Ages 60–80
A study can be open while its sites in Thailand have not opened yet or have stopped. Only those recruiting at a site in Thailand →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
44 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 8 · Phase 3 8 · Phase 4 9
First in 2004; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 97 across the 40 interventional studies, 80 across the 4 observational. Of the 30 that completed or were terminated, 4 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 44 have an industry lead sponsor. The 10 most frequent:
Ministry of Health, Thailand is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Ministry of Health, Thailand has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
1 of the studies in Osteoarthritis, Knee with a site in Thailand that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04318041Phase 3TRB ChemedicaEvaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 44 studies in Osteoarthritis, Knee with a site in Thailand, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to compare postoperative pain score between perioperative intravenous ketamine and placebo in patients undergoing unilateral total knee arthroplasty under general anesthesia. The main question[s] it aims to answer are:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participant will receive intraoperative ketamine during total knee arthroplasty by Ketamine 0.5mg /kg loading then 0.25 mg/kg/hours until end of surgery
Drug: Ketamine group
Participant will receive intraoperative normal saline during total knee arthroplasty
Drug: Placebo group
Participants will receive intraoperative ketamine during total knee arthroplasty
Participants will receive intraoperative normal saline during total knee arthroplasty
Postoperative pain score at rest and movement
pain score at rest and movement by numeric rating scale 0-10
Time frame: post operative time at 0 ,2 ,4 ,8 ,12 ,18 ,24 hours
First time to receive intravenous analgesic drug
First time to receive intravenous analgesic drug after operation was finished
Time frame: First time to receive intravenous analgesic drug ( From finished anesthetic time until First time to receive intravenous analgesic drug(minute)
Morphine consumption
Post operative morphine consumption or morphine equivalent (milligram)
Time frame: post operative time at 0 ,2 ,4 ,8 ,12 ,18 ,24 hours
Length of hospital stay
Length of hospital stay : When participant admit to discharge
Time frame: Time that patient was admited to hospital until patient was discharge from hospital.
side effect and complication from ketamine and opioid
Number of Participants with side effect form Ketamine and opioid: Hallucination, Nightmare, Arrythmia , Nausea vomiting respiratory distress ,Pruritus within 24 hours after operation. Do you have hallucination or nightmare? : yes no Nausea vomiting : - Severity of nausea 4 scale : 0 = No 1. =minimal nausea and vomiting don't need medication 2. = nausea and vomiting participant was improved when received medication 3= nausea and vomiting participant wasn't improved when received medication Pruritus score 0= no 1= minimal 2= severe and need medication respiratory distress : sedation scale 0 = awake 1. minimal sedation : response to verbal conversation 2. moderated sedation : sleeping but easy to response to verbal conversation 3. deep sedation : difficult to response to
Time frame: post operative time within 24 hours
Started Jan 2024 (actual). Primary completion is estimated for Dec 2025, 23 months after the start.
Of 88 non-industry phase 4 interventional studies under Osteoarthritis, Knee, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 32. This study's planned 23 months is above that.
Counting every sponsor, half of 97 studies reached it within 19 months; a quarter within 10 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ketamine
Ministry of Health, Thailand